Published in Vaccine on April 09, 1999
Influence of HLA-DRB1 alleles on lymphoproliferative responses to a naturally processed and presented measles virus phosphoprotein in measles immunized individuals. Hum Immunol (2004) 0.81
Epitope dampening monotypic measles virus hemagglutinin glycoprotein results in resistance to cocktail of monoclonal antibodies. PLoS One (2013) 0.81
Measles humoral and cell-mediated immunity in children aged 5-10 years after primary measles immunization administered at 6 or 9 months of age. J Infect Dis (2013) 0.80
Effects of interleukin-12 and interleukin-15 on measles-specific T-cell responses in vaccinated infants. Viral Immunol (2008) 0.78
Effect of breast-feeding on antibody response to conjugate vaccine. Lancet (1990) 1.72
Comparison of esophageal, rectal, axillary, bladder, tympanic, and pulmonary artery temperatures in children. J Pediatr (1998) 1.38
Energy balance during recovery from malnutrition. Am J Clin Nutr (1976) 1.31
Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22
Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr (1997) 1.10
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
Reduced measles immunity in infants in a well-vaccinated population. Pediatr Infect Dis J (1992) 1.01
Effect of breast-feeding on immune response to BCG vaccination. Lancet (1989) 0.98
Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J (1995) 0.97
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2012) 0.93
The use of the diary as a data collection technique. West J Nurs Res (1994) 0.91
Changing trends in infant feeding patterns in the Northwest Territories 1973-1979. Can J Public Health (1983) 0.89
Total daily energy expenditure of healthy, free ranging school children. Am J Clin Nutr (1980) 0.89
Differential modulation of the immune response by breast- or formula-feeding of infants. Acta Paediatr (1997) 0.86
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J (2000) 0.85
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine (1995) 0.83
Validity of convenient indicators of obesity. Hum Biol (1991) 0.83
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J (1999) 0.80
Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia. Can Dis Wkly Rep (1989) 0.80
Transfer of maternal specific cell-mediated immunity to the fetus. Clin Exp Immunol (1987) 0.80
The epidemiology of childhood asthma in Red Deer and Medicine Hat, Alberta. Can Respir J (2001) 0.79
Prospective trial of timing of bacillus Calmette-Guérin vaccination in Canadian Cree infants. Am Rev Respir Dis (1989) 0.79
Measurement of total body potassium in premature infants by means of a whole-body counter. J Pediatr Gastroenterol Nutr (1986) 0.79
Kinetics of immunologic responses after primary MMR vaccination. Vaccine (1997) 0.79
Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine (1996) 0.79
[Quality evaluation of primary health care in an urban area of southern Brazil]. Rev Saude Publica (1994) 0.78
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination. Dev Biol Stand (1998) 0.77
Human colostrum contains an activity that inhibits the production of IL-2. Clin Exp Immunol (1991) 0.77
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old. Scand J Infect Dis (1995) 0.77
Immunogenicity of a five-component acellular pertussis vaccine in infants and young children. Arch Pediatr Adolesc Med (1994) 0.77
Recent Canadian deaths from malaria acquired in Africa. Can Dis Wkly Rep (1989) 0.76
Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. J Pediatr (1999) 0.76
Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities. Arch Pediatr Adolesc Med (1994) 0.76
Comparison of convenient indicators of obesity. Am J Clin Nutr (1990) 0.76
Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J Infect Dis (1992) 0.76
Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J (1995) 0.76
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine. Vaccine (1997) 0.76
Studying refugee health. Can Fam Physician (1989) 0.75
Malaria prophylaxis. Can Fam Physician (1989) 0.75
The launch of an infant Haemophilus influenzae type B immunization programme in Iceland. Arctic Med Res (1991) 0.75
Changing the model of practice: geriatric long term care in an acute care hospital. Can Nurse (1993) 0.75
Reversible zidovudine-induced pure red cell aplasia. AIDS (1999) 0.75
Stability of BCG vaccine (intravesical) Theracys/BCG therapeutic ImmuCyst and its importance in clinical efficacy. Dev Biol Stand (1992) 0.75
Interesting case: an unusual case of oral ulceration. Br J Oral Maxillofac Surg (2005) 0.75
Energy cost of catch-up growth in malnourished children. Nutr Metab (1977) 0.75
Infant feeding practices in a poor district of Santo Domingo. Ecol Food Nutr (1994) 0.75
Effects of mother's smoking on their infants' body composition as determined by total body potassium. Pediatr Res (1986) 0.75
Standardization of BCG multiple puncture 40 mg and BCG live (intravesical) Theracys/BCG therapeutic Immucyst. Dev Biol Stand (1992) 0.75
Smokeless tobacco: a northern perspective. Can Nurse (1987) 0.75
[Research on human vaccine and its trends of application]. Zhonghua Yi Xue Za Zhi (1998) 0.75
A comparison of alternate immunization regimes for measles in vaccinated populations. Vaccine (1999) 0.75